Abstract
Aims: Increasing evidence indicates that FK866, a specific noncompetitive nicotinamide phosphoribosyl transferase inhibitor, exhibits a protective eff......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
